Neurology · San Diego, CA
NPI
1255699948
Since 2012
Specialty
Neurology
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
200 W Arbor Dr, Mc 8465
San Diego, CA, 92103
Phone (619) 543-6222
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$927K
2,078 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Amanda E Yu prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 357 prescriptions and refills. In total Amanda E Yu wrote 2,078 Medicare prescriptions that cost $927K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 357 | 937 | 111 | $30K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 215 | 594 | 68 | $18K |
| Amantadine Amantadine Hcl | 99 | 271 | 36 | $3,312 |
| Ropinirole Er Ropinirole Hcl | 81 | 211 | 30 | $5,798 |
| Neupro Rotigotine | 79 | 139 | 22 | $129K |
| Donepezil Hcl Generic | 60 | 153 | 21 | $1,060 |
| Entacapone Generic | 59 | 147 | 19 | $12K |
| Mirtazapine Generic | 51 | 158 | 21 | $942 |
| Clonazepam Generic | 46 | 46 | Under 11 | $384 |
| Quetiapine Fumarate Generic | 45 | 129 | 16 | $700 |
| Ropinirole Hcl Generic | 45 | 108 | 13 | $978 |
| Gabapentin Generic | 44 | 135 | 22 | $1,196 |
| Topiramate Generic | 42 | 105 | 14 | $995 |
| Levetiracetam Generic | 35 | 86 | 13 | $1,859 |
| Rytary Carbidopa/Levodopa | 35 | 46 | Under 11 | $39K |
Brand drugs: 312 claims; generic drugs: 1,766 claims; opioid claims: 11.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Amanda E Yu were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.